Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa-Reference-Cited by-同舟云学术

Is there a role for doravirine in African HIV treatment programmes? A large observational resistance study in South Africa

Published:2021-05 Issue:5 Volume:24 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc

Author:

Steegen Kim¹²^ORCID,Moorhouse Michelle³⁴,Wensing Annemarie MJ³⁵^ORCID,Venter Willem DF³,Hans Lucia¹²

Affiliation:

1. Department of Molecular Medicine and Haematology National Health Laboratory Services Johannesburg South Africa

2. Department of Molecular Medicine and Haematology University of the Witwatersrand Johannesburg South Africa

3. Ezintsha, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

4. Global Medical Affairs ViiV HealthCare Johannesburg South Africa

5. Translational Virology Department of Medical Microbiology University Medical Center Utrecht Utrecht The Netherlands

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25706

Reference32 articles.

1. UNAIDS.UNAIDS data 2020.2020.

2. WHO.Interim guidelines: Updated recommendations on first‐line and second‐line antiretroviral regimens and post‐exposure prophylaxis and recommendations on early infant diagnosis of HIV.2018.

3. WHO.Policy brief: Update of recommendations on first‐ and second‐line antiretroviral regimens.2019.

4. Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

5. Cutting the cost of South African antiretroviral therapy using newer, safer drugs

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Where does doravirine fit in current antiretroviral therapy?;The Lancet HIV;2024-09

2. Retrospective study of the prevalence of acquired drug resistance after failed antiretroviral therapy in Libya;E MEDITERR HEALTH J;2024

3. Doravirine responses to HIV-1 viruses bearing mutations to NRTIs and NNRTIs under in vitro selective drug pressure;Journal of Antimicrobial Chemotherapy;2023-06-12

4. Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry;International Journal of Antimicrobial Agents;2023-03

5. Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance;AIDS Research and Therapy;2023-02-07